SOCS1 gene mutations in patients with diffuse large B-cell lymphoma

SOCS1 gene mutations in patients with diffuse large B-cell lymphoma

Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous group of diseases, which accounts for 30% of all non-Hodgkin lymphomas. Current molecular studies have confirmed that there are several DLBCL subtypes characterized by different cellular origin, cytogenetic profile, molecular genetic disorders...

Full description

Bibliographic Details
Main Authors: O A Gavrilina, E E Zvonkov, B V Biderman, N A Severina, E N Parovichnikova
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2015-07-01
Series:Терапевтический архив
Subjects:
diffuse large b-cell lymphoma
socs1 gene
chemotherapy
poor predictors
Online Access:https://ter-arkhiv.ru/0040-3660/article/view/31812

Similar Items

Similar Items